Pineal region tumors in children

Current Opinion in Neurology

Volumn 23, Issue 6, 2010, Pages 576-582

  Dhall, Girish ^a   Khatua, Soumen ^b   Finlay, Jonathan L ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

Author keywords

children; germinoma; nongerminomatous germ cell tumors; pineoblastoma

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; IFOSFAMIDE; VINBLASTINE; VINCRISTINE;

ANASTOMOSIS; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BRAIN VENTRICLE PERITONEUM SHUNT; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHILD; DRUG DOSE COMPARISON; GENE MUTATION; GERM CELL TUMOR; HUMAN; MAINTENANCE THERAPY; MORBIDITY; MULTIPLE CYCLE TREATMENT; PINEAL BODY TUMOR; PROGRESSION FREE SURVIVAL; REVIEW; SURVIVAL RATE;

AGE FACTORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTINEOPLASTIC PROTOCOLS; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; HUMANS; INFANT; NEOPLASMS, GERM CELL AND EMBRYONAL; PINEALOMA; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 78649634747     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/WCO.0b013e3283404ef1     Document Type: Review

References (72)

1. CBTRUS (2007-2008). Statistical Report: Primary brain tumors in the United States.
2. Matsutani M. Pineal germ cell tumors. Prog Neurol Surg 2009; 23:76-85.
3. Hirato J, Nakazato Y. Pathology of pineal region tumors. J Neurooncol 2001; 54:239-249.
4. Louis DN, Ohgaki H, Wiestler OD, Cavanee WK. Tumors of the pineal region. WHO classification of tumors of the central nervous system. Lyon: IARC Press, 2007. pp. 121-126.
5. Li MH, Bouffet E, Hawkins CE, et al. Molecular genetics of supratentorial primitive neuroectodermal tumors and pineoblastoma. Neurosurg Focus 2005; 19:E3.
6. Duffner PK, Horowitz ME, Krischer JP, et al. The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experience. Neuro Oncol 1999; 1:152-161.
7. Jakacki RI, Zeltzer PM, Boyett JM, et al. Survival and prognostic factors following radiation and/or chemotherapy for primitive neuroectodermal tumors of the pineal region in infants and children: a report of the Children's Cancer Group. J Clin Oncol 1995; 13:1377-1383.
8. Geyer JR, Zeltzer PM, Boyett JM, et al. Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Children's Cancer Group. J Clin Oncol 1994; 12:1607-1615.
9. Geyer JR, Sposto R, Jennings M, et al. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group. J Clin Oncol 2005; 23:7621-7631.
10. Hinkes BG, von Hoff K, Deinlein F, et al. Childhood pineoblastoma: experiences from the prospective multicenter trials HIT-SKK87, HIT-SKK92 and HIT91. J Neurooncol 2007; 81:217-223.
11. Fangusaro J, Finlay J, Sposto R, et al. Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and II experience. Pediatr Blood Cancer 2008; 50:312-318.
12. Cohen BH, Zeltzer PM, Boyett JM, et al. Prognostic factors and treatment results for supratentorial primitive neuroectodermal tumors in children using radiation and chemotherapy: a Children's Cancer Group randomized trial. J Clin Oncol 1995; 13:1687-1696.
13. Pizer BL, Weston CL, Robinson KJ, et al. Analysis of patients with supratentorial primitive neuro-ectodermal tumours entered into the SIOP/UKCCSG PNET 3 study. Eur J Cancer 2006; 42:1120-1128.
14. Jakacki R, Zhou T, Holmes E, et al. Outcome for patients with nonpineal supratentorial PNET treated with carboplatin as radiosensitizer during radiotherapy followed by adjuvant cyclophosphamide and vincristine: preliminary results of COG 99701. Neuro-oncology 2008; 10:485.
15. Chintagumpala M, Hassall T, Palmer S, et al. A pilot study of risk-adapted radiotherapy and chemotherapy in patients with supratentorial PNET. Neurooncology 2009; 11:33-40.
16. Gururangan S, McLaughlin C, Quinn J, et al. High-dose chemotherapy with autologous stem-cell rescue in children and adults with newly diagnosed pineoblastomas. J Clin Oncol 2003; 21:2187-2191.
17. Jennings MT, Gelman R, Hochberg F. Intracranial germ-cell tumors: natural history and pathogenesis. J Neurosurg 1985; 63:155-167.
18. Matsutani M. Clinical management of primary central nervous system germ cell tumors. Semin Oncol 2004; 31:676-683.
19. Matsutani M. Treatment of intracranial germ cell tumors: The Second Phase II Study of Japanese GCT Study Group [abstract GCT 13]. Neuro-oncology 2008; 10:420.
20. Fujimaki T, Matsutani M, The Japanese Pediatric Brain Tumor Study Group. HCGp-producing germinoma: analysis of Japanese Pediatric Brain Tumor Study Group results [abstract G5]. Neuro-oncology 2005; 7:518.
21. Sawamura Y, de Tribolet N, Ishi N, et al. Management of primary intracranial germinomas: diagnostic surgery or radical resection? J Neurosurg 1997; 87:262-266.
22. O'Callaghan AM, Katapodis O, Ellison DW, et al. The growing teratoma syndrome in a nongerminomatous germ cell tumor of the pineal gland: a case report and review. Cancer 1997; 80:942-947.
23. Stephens AW, Gonin R, Hutchins GD, Einhorn L. Positron emission tomography evaluation of residual radiographic abnormalities in postchemotherapy germ cell tumor patients. J Clin Oncol 1996; 14:1637-1641.
24. Kelly PA, Metcalfe K, Evanson J, et al. Positron emission tomography in the diagnosis and management of intracranial germ cell tumors. Horm Res 2009; 72:190-196.
25. Shibamato Y, Abe M, Yamashita J, et al. Treatment results of intracranial germinoma as a function of the irradiated volume. Int J Radiat Oncol Biol Phys 1998; 15:285-290.
26. Aoyama H, Shirato H, Kakuto Y, et al. Pathologically-proven intracranial germinoma treated with radiation therapy. Radiother Oncol 1998; 47:201-205.
27. Spiegler BJ, Bouffet E, Greenberg ML, et al. Change in neurocognitive functioning after treatment with cranial radiation in childhood. J Clin Oncol 2004; 22:706-713.
28. Maity A, Shu HK, Janss A, et al. Craniospinal radiation in the treatment of biopsy-proven intracranial germinomas: twenty five years experience in a single center. Int J Radiat Oncol Biol Phys 2000; 46:1171-1176.
29. Kretschmar C, Kleinberg L, Greenberg M, et al. Preradiation chemotherapy with response-based radiation therapy in children with central nervous germ cell tumors: a report from the Children's Oncology group. Pediatr Blood Cancer 2007; 48:285-291.
30. Rogers SJ, Mosleh-Shirazi MA, Saran FH. Radiotherapy of localized intracranial germinoma: time to sever historical ties? Lancet Oncol 2005; 6:509-519.
31. Ogawa K, Shikama N, Toita T, et al. Long-term results of radiotherapy for intracranial germinoma: a multiinstitutional retrospective review of 126 patients. Int J Radiat Oncol Biol Phys 2004; 58:705-713.
32. Hardenbergh PH, Golden J, Billet A, et al. Intracranial germinoma: the case for lower dose radiation therapy. Int J Radiat Oncol Biol Phys 1997; 39:419-426.
33. Shirato H, Nishio M, Sawamura Y, et al. Analysis of long-term treatment of intracranial germinoma. Int J Radiat Oncol Biol Phys 1997; 37:511-515.
34. Yen SH, Chen YW, Huang PI, et al. Optimal treatment for intracranial germinoma: Can we lower radiation dose without chemotherapy? Int J Radiat Oncol Biol Phys 2010; 77:980-987.
35. Balmaceda C, Heller G, Rosenblum M, et al. Chemotherapy without irradiation: a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study. J Clin Oncol 1996; 14:2908-2915.
36. Kellie SJ, Boyce H, Dunkel IJ, et al. Intensive cisplatin and cyclophosphamide-based chemotherapy without radiotherapy for intracranial germinomas: failure of a primary chemotherapy approach. Pediatric Blood Cancer 2004; 43: 126-133.
37. Afzal S, Wherrett D, Bartels U, et al. Challenges and difficulties in management of patients with intracranial germ cell tumor having diabetes insipidus treated with cisplatin and or ifosfamide based chemotherapy. Neuro-oncology 2008; 10:417.
38. Nasjla Sabada Silva, Cappellano AM, Diez B, et al. Primary chemotherapy for intracranial germ cell tumors: Results of the Third International Germ Cell Tumor Study. Pediatr Blood Cancer 2010; 54:377-383.
39. Calaminus G, Alapetite C, Kortmann R, et al. Outcome of localized and metastatic germinoma treated according to SIOP CNS GCT96 [abstract GCT 04]. Neuro-oncology 2010; 12:ii28.
40. Matsutani M. Long-term follow-up of germinomas treated by ventricular irradiation with 24 Gy and concurrently administered carboplatin and etoposide chemotherapy [abstract GCT 02]. Neuro-oncology 2010; 12:ii28.
41. Alapetite C, Brisse H, Patte C, et al. Pattern of relapse and outcome of nonmetastatic germinoma patients treated with chemotherapy and limited field radiation: the SFOP experience. Neuro Oncol 2010 [Epub ahead of print].
42. Haas-Kogan DA, Missett BT, Wara WM, et al. Radiation therapy for intra cranial germ cell tumors. Int J Radiat Oncol Biol Phys 2003; 56:511-518.
43. Khatua S, Dhall G, O'Neil S, et al. Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation. Pediatr Blood Cancer 2010; 55:42-46.
44. Lafay-Cousin L, Millar B-A, Mabbot D, et al. Limited-field radiation for bifocal germinoma. Int J Radiat Oncol Biol Phys 2006; 65:486-492.
45. Huang P-I, Chen Y-W, Wong T-T, et al. Extended focal radiotherapy of 30Gy alone for intracranial synchronous bifocal germinoma: single institute experience. Childs Nerv Syst 2008; 24:315-321.
46. Williams SD, Stablein DM, Einhorn LH, et al. Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer. N Engl J Med 1987; 317:1433-1438.
47. Einhorn LH. Cancer of the testis: a new paradigm. Hosp Pract (Off Ed) 1986; 21:165-172; 175-178.
48. Einhorn LH, Williams SD. Chemotherapy of disseminated testicular cancer. A random prospective study. Cancer 1980; 46:1339-1344.
49. Allen JC, Bosl G, Walker R. Chemotherapy trials in recurrent primary intracranial germ cell tumors. J Neurooncol 1985; 3:147-152.
50. Allen JC, Kim JH, Packer RJ. Neoadjuvant chemotherapy for newly diagnosed germ-cell tumors of the central nervous system. J Neurosurg 1987; 67:65-70.
51. Chang TK, Wong TT, Hwang B. Combination chemotherapy with vinblastine, bleomycin, cisplatin, and etoposide (VBPE) in children with primary intracranial germ cell tumors. Med Pediatr Oncol 1995; 24:368-372.
52. Matsukado Y, Abe H, Tanaka R, et al. Cisplatin, vinblastine and bleomycin (PVB) combination chemotherapy in the treatment of intracranial malignant germ cell tumors: a preliminary report of a phase II study-The Japanese Intracranial Germ Cell Tumor Study Group. Gan No Rinsho 1986; 32:1387-1393.
53. Patel SR, Buckner JC, Sminthson WA, et al. Cisplatin-based chemotherapy in primary central nervous system germ cell tumors. J Neurooncol 1992; 12:47-52.
54. Robertson PL, DaRosso RC, Allen JC. Improved prognosis of intracranial nongerminoma germ cell tumors with multimodality therapy. J Neurooncol 1997; 32:71-80.
55. Calaminus G, Bamberg M, Jurgens H, et al. Impact of surgery, chemotherapy and irradiation on long-term outcome of intracranial malignant nongermino-matous germ cell tumors: results of the German Cooperative Trial MAKEI 89. Klin Padiatr 2004; 216:141-149.
56. Baranzelli, C. Carboplatin-based chemotherapy (CT) and focal radiation (RT) in primary cerebral germ cell tumor (GCT): a French Society of Pediatric Oncology (SFOP) experience [abstract]. Proc Am Soc Clin Oncol 1999; 18:140A.
57. Calaminus G, Bamberg M, Barenzelli MC, et al. Intracranial germ cell tumors: a comprehensive update of the European data. Neuropediatrics 1994; 25:26-32.
58. Goldman S, Bouffet E, Fisher G, et al. A phase II trial of neoadjuvant chemotherapy +/\second-look surgery prior to radiotherapy for nongermi-nomatous germ cell tumors: Children's Oncology Group Study ACNS0122 [abstract GCT 06]. Neuro-oncology 2010; 12: ii29.
59. Dearnaley DP, A'Hern RP, Whittaker S, Bloom HJ. Pineal and CNS germ cell tumors: Royal Marsden Hospital experience 1962-1987. Int J Radiat Oncol Biol Phys 1990; 18:773-781.
60. Hoffman HJ, Otsubo H, Hendrick EB, et al. Intracranial germ-cell tumors in children. J Neurosurg 1991; 74:545-551.
61. Matsutani M,Sano K, Takakura K, et al. Primary intracranial germ cell tumors: a clinical analysis of 153 histologically verified cases. J Neurosurg 1997; 86:446-455.
62. Constine LS, Woolf PD, Caan D, et al. Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med 1993; 328:87-94.
63. Copeland DR, Fletcher JM, Pfeferbaum LB, et al. Neuropsychological sequelae of childhood cancer in long-term survivors. Pediatrics 1985; 75:745-753.
64. Mulhern RK, Kepner JL, THomas PR, et al. Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study. J Clin Oncol 1998; 16:1723-1728.
65. Fuller BG, Kapp DS, Cox R. Radiation therapy of pineal region tumors: 25 new cases and a review of 208 previously reported cases. Int J Radiat Oncol Biol Phys 1994; 28:229-245.
66. Gobel U, Schneider DT, Calaminus G, et al. Germ-cell tumors in childhood and adolescence. GPOH MAKEI and the MAHO study groups. Ann Oncol 2000; 11:263-271.
67. SIOP. CNS GCT 96 Interim Analysis, 2003.
68. Calaminus, G. International Society of Pediatric Oncology (SIOP) Education Book 2005. Vancouver, Canada. Matsutani M. Excellent 10-year's OS & PFS of patients with non germino-matous germ cell tumors treated by surgery, radiation and chemotherapy [abstract GCT 03]. Neuro-oncology 2010; 12:ii28.
69. Chen MJ, Santos AS, Sakuraba RK, et al. Intensity-modulated and 3D-conformal radiotherapy for whole-ventricular irradiation as compared with conventional whole-brain irradiation in the management of localized central nervous system germ cell tumors. Int J Radiat Oncol Biol Phys 2010; 76:608-614.
70. Calaminus G, Nicholson J, Frappaz D, et al. Localized and metastatic non germinoma treated according to the SIOP CNS GCT96 protocol. Update on risk profiles and outcome [abstract GCT 05]. Neuro-oncology 2010; 12:ii28.
71. Modak S, Gardner S, Dunkel IJ, et al. Thiotepa-based high-dose chemotherapy with autologous stem-cell rescue in patients with recurrent or progressive CNS germ cell tumors. J Clin Oncol 2004; 22:1934-1943. (Pubitemid 41095186)
72. Bouffet E. High dose etoposide and thiotepa for refractory and recurrent malignant intracranial germ cell tumors, No. 38. Presented at 9th International Symposium on Pediatric Neuro-oncology, 2000; San Francisco, CA, USA.